Guerbet (XPAR:GBT) Valuation Rank


XPAR:GBT Guerbet SA XPAR:GBT
66 GF Score
Price €8.92
GF Value €19.63
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Guerbet Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Guerbet Valuation Rank Related Terms

XPAR:GBT
66GF Score
Guerbet SA XPAR:GBT
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guerbet (XPAR:GBT) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of €8.92 is trading 54.6% below its estimated GF Value™ of €19.63. GuruFocus considers Guerbet to be Possible Value Trap.

Key valuation signals for XPAR:GBT:

  • Valuation Rank:
  • GF Value™: €19.63 vs. price of €8.92 (54.6% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XPAR:GBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guerbet Business Description

Other Exchanges 0ELV:UK4G8:Germany
Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
66GF Score

Get the complete analysis for XPAR:GBT

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.92
Price
€19.63
GF Value